| Literature DB >> 29202875 |
Ann-Kathrin Lederer1, Przemyslaw Pisarski2, Lampros Kousoulas2, Stefan Fichtner-Feigl2, Carolin Hess3, Roman Huber4.
Abstract
BACKGROUND: The purpose of this review was to identify the relationship between the gut microbiome and the development of postoperative complications like anastomotic leakage or a wound infection. Recent reviews focusing on underlying molecular biology suggested that postoperative complications might be influenced by the patients' gut flora. Therefore, a review focusing on the available clinical data is needed.Entities:
Keywords: Anastomotic leakage; Gastrointestinal microbiome; Microbiota; Postoperative complications; Surgical wound infection
Mesh:
Year: 2017 PMID: 29202875 PMCID: PMC5715992 DOI: 10.1186/s12893-017-0325-8
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Probiotics and synbiotics in the included RCTs
| Author | Preparation | Duration of application |
|---|---|---|
| Kanazawa et al. | Bifidobacterium breve | Start: 1 day postoperative |
| Reddy et al. | Lactobacillus acidophilus | Start: 1 day preoperative |
| Sugawara et al. | Bifidobacterium breve | Start: 14 days preoperative |
| Liu et al. | Lactobacillus plantarum | Start: 6 days preoperative |
| Eguchi et al. | Bifidobacterium breve | Start: 2 days preoperative |
| Usami et al. | Bifidobacterium breve | Start: 14 days preoperative |
| Zhang et al. | Bifidobacterium longum | Start: 5 days preoperative |
| Okazaki et al. | Bifidobacterium breve | Start: 7 days preoperative |
| Tanaka et al. | Bifidobacterium breve | Start: Preoperative, day not reported |
| Tanaka et al. | Streptococcus faecalis | Start: 1 day postoperative |
Summary of included publications
| Author | Kanazawa | Reddy | Sugawara | Liu | Eguchi |
|---|---|---|---|---|---|
| Year | 2005 | 2006 | 2006 | 2010 | 2010 |
| Country | Japan | UK | Japan | China | Japan |
| Study type | RCT | RCT | RCT | RCT | RCT |
| Treatment | Synbiotics vs. no Treatment | * | ** | Probiotic vs. Placebo | Synbiotics vs. no Treatment |
| Number of patients included | 44 (21 + 23) | 88 (24 + 22 + 20 + 22) | 81 (41 + 40) | 100 (50 + 50) | 50 (25 + 25) |
| Area of surgery | Liver | Colon | Liver | Colon | Liver (Transplant) |
| Method of quantification | Culture | PCR | Culture | PCR | Culture |
| C-reactive Protein | Recovery faster | No difference | ↓ | n. s. | n. s. |
| White blood | Recovery faster | n. s. | ↓ | n. s. | n. s. |
| SIRS | n. s. | No difference | n. s. | No difference | n. s. |
| Organic acids | ↑ | n. s. | ↑ | n. s. | n. s. |
| Stool pH | No difference | n. s. | No difference | n. s. | n. s. |
| Rate of infections | ↓ | No difference | ↓ | ↓ | ↓ |
| Number of pathogenetic bacteria | ↓ | ↓ | No difference | ↓ | No difference |
| Number of Lactobacilli and Bifidobacteria | ↑ | n. s. | No difference | ↑ | n. s. |
If not specified elsewhere, the arrows show the postoperative comparison of the synbiotic/probiotic-treated patients compared to control groups
n. s. not specified, RCT Randomized controlled trial, SIRS Systemic inflammatory response syndrome
*Group 1: Mechanical bowel preparation (MBP) only, Group 2: MBP + Neomycin, Group 3: MBP + Neomycin + Synbiotics, Group 4: Synbiotics + Neomycin, no MBP
**Preoperative synbiotic treatment vs. no treatment, both groups were treated with synbiotics postoperatively
Summary of included publications
| Author | Usami | Zhang | Okazaki | Ohigashi | Tanaka |
|---|---|---|---|---|---|
| Year | 2010 | 2012 | 2013 | 2013 | 2012 |
| Country | Japan | China | Japan | Japan | Japan |
| Study type | RCT | RCT | RCT | Cohort | RCT |
| Treatment | Synbiotics vs. no Treatment | Probiotics vs. Placebo | Synbiotics vs. no Treatment | n. s. | Synbiotics vs. Probiotics |
| Number of patients included | 61 (29 + 32) | 60 (30 + 30) | 48 (25 + 23) | 81 | 64 (30 + 34) |
| Area of surgery | Liver | Colon | Pankreas/Bile-System | Colon | Oesophagus |
| Method of quantification | Culture | Culture | PCR | PCR | PCR |
| C-reactive Protein | No difference | ↓ | No difference | n. s. | ↓ |
| White blood cell count | ↓ | n. s. | No difference | n. s. | ↓ |
| SIRS | ↓ | n. s. | ↓ | n. s. | ↓ |
| Organic acids in stool | ↓ | n. s. | ↑ | ↓ a | ↑ |
| Stool pH | ↓ | n. s. | ↓ | No difference | ↓ |
| Rate of infections | ↓ | ↓ | ↓ | 7,4% | ↓ |
| Number of pathogenetic bacteria | ↑ | ↓ | ↓ | ↑ a | ↓ |
| Number of Lactobacilli and Bifidobacteria | ↓ | ↑ | ↑ | ↓ a | ↑ |
If not specified elsewhere, the arrows show the postoperative comparison of the synbiotic/probiotic-treated patients compared to control groups
n. s. not specified, RCT Randomized controlled trial, SIRS Systemic inflammatory response syndrome
aCompared to preoperative measures
Fig. 1Process of screening and selection